These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37245535)

  • 1. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
    Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
    Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
    Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
    Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.
    Chen S; Liu Y; Zhou H
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
    Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
    Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases.
    Zhu W; Zheng D; Wang D; Yang L; Zhao C; Huang X
    Front Cell Dev Biol; 2021; 9():698751. PubMed ID: 34249948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissenting degradation: Deubiquitinases in cell cycle and cancer.
    Bonacci T; Emanuele MJ
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):145-158. PubMed ID: 32201366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-specific protease 20 in human disease: Emerging role and therapeutic implications.
    Qin B; Zhou L; Wang F; Wang Y
    Biochem Pharmacol; 2022 Dec; 206():115352. PubMed ID: 36423672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin specific peptidases and prostate cancer.
    Guo Y; Cui S; Chen Y; Guo S; Chen D
    PeerJ; 2023; 11():e14799. PubMed ID: 36811009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Assays for Dynamic Quantification of Deubiquitinase Activity and Inhibition.
    Moghadasi SA; Moraes SN; Harris RS
    J Mol Biol; 2023 Dec; 435(23):168316. PubMed ID: 37858708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the development of deubiquitinases inhibitors as antitumor agents.
    Zheng LL; Wang LT; Pang YW; Sun LP; Shi L
    Eur J Med Chem; 2024 Feb; 266():116161. PubMed ID: 38262120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner.
    Hou Z; Shi W; Feng J; Wang W; Zheng E; Lin H; Yu C; Li L
    Int J Biol Macromol; 2021 Jun; 181():1081-1091. PubMed ID: 33864866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP28 regulates deubiquitination of histone H2A and cell proliferation.
    Li F; Han H; Sun Q; Liu K; Lin N; Xu C; Zhao Z; Zhao W
    Exp Cell Res; 2019 Jun; 379(1):11-18. PubMed ID: 30910399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.
    Snyder NA; Silva GM
    J Biol Chem; 2021 Sep; 297(3):101077. PubMed ID: 34391779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
    Kumar P; Kumar P; Mandal D; Velayutham R
    Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
    Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
    ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.
    Hewitt CS; Krabill AD; Das C; Flaherty DP
    Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the bi-specificity of USP25 and USP28 inhibitors.
    Patzke JV; Sauer F; Nair RK; Endres E; Proschak E; Hernandez-Olmos V; Sotriffer C; Kisker C
    EMBO Rep; 2024 Jul; 25(7):2950-2973. PubMed ID: 38816515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation.
    Palazón-Riquelme P; Worboys JD; Green J; Valera A; Martín-Sánchez F; Pellegrini C; Brough D; López-Castejón G
    EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30206189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25.
    Valero R; Bayés M; Francisca Sánchez-Font M; González-Angulo O; Gonzàlez-Duarte R; Marfany G
    Genome Biol; 2001; 2(10):RESEARCH0043. PubMed ID: 11597335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinases and cancer: A snapshot.
    Singh N; Singh AB
    Crit Rev Oncol Hematol; 2016 Jul; 103():22-6. PubMed ID: 27211605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.